Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
VOR: Vor Biopharma Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
VOR
The Story
VOR
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+0.0% / yr
Operating margin
0.0%
ROIC
-76.1%
Financially safe
Stretched
Debt / equity
-0.02×
Interest coverage
0.0×
Current ratio
31.15×
Vor Biopharma Inc.
VOR
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Vor Biopharma Inc.
VOR
NASDAQ
·
USD
·
Closed
$21.15
−2.98%
$21.15
−$0.65 (2.98%)
52W Range
34th
pctl
Volume
0.76×
avg
Mkt Cap
1.15B
USD
P/E
-0.0
TTM
Div Yield
–
ann
52W Range
34th
pctl
Volume
0.76×
avg
Market Cap
1.15B
USD
P/E Ratio
-0.0
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings